Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2009
10/22/2009US20090264512 exposing the sample to an aptamer that specifically binds a protein selected from Listeria monocytogenes internalin B protein and Listeria monocytogenes internalin A protein; for treating or preventing Listeria infection
10/22/2009US20090264511 Compositions and methods for inhibiting expression of factor vii gene
10/22/2009US20090264510 Double helical oligonucleotides interfering with mRNA used as effective anticancer agents
10/22/2009US20090264509 Adenoviral vector-based foot-and-mouth disease vaccine
10/22/2009US20090264508 Focused Libraries, Functional Profiling, Laser Selex, and Deselex
10/22/2009US20090264507 Method of diagnosing gum disease-wound healing using single nucleotide polymorphism profiles
10/22/2009US20090264506 Delivery of polynucleotide agents to the central nervous system
10/22/2009US20090264505 Methods and compositions for rnai mediated inhibition of gene expression in mammals
10/22/2009US20090264504 For modulating human immunodeficiency virus (HIV) gene expression ; nucleic acids with a pyrimidine modification; AIDS
10/22/2009US20090264503 Short interference ribonucleic acids for treating allergic diseases
10/22/2009US20090264502 Compositions and their uses directed to hsp27
10/22/2009US20090264501 Methods and Compositions to Inhibit P2x7 Receptor Expression
10/22/2009US20090264500 3-substituted-1,5-diarly-2-alkyl-pyrroles highly selective and orally effective cox-2 inhibitors
10/22/2009US20090264499 Cathepsin C Inhibitors
10/22/2009US20090264498 Cathepsin C Inhibitors
10/22/2009US20090264497 Stable pharmaceutical formulation comprising a hmg-coa reductase inhibitor
10/22/2009US20090264496 Compounds, Compositions and Methods for Making the Same
10/22/2009US20090264495 Oral sustained-release pharmaceutical composition of indapamide, production and use thereof
10/22/2009US20090264494 Use of neuroprotective 3-substituted indolone compositions
10/22/2009US20090264493 Process for Producing Aqueous Solution of Doripenem
10/22/2009US20090264492 Pharmaceutical composition for the treatment of a fungal skin disorder and a method for the preparation thereof
10/22/2009US20090264491 Methods and compositions for treating post-operative pain comprising clonidine
10/22/2009US20090264490 Clonidine formulations in a biodegradable polymer carrier
10/22/2009US20090264489 Method for Treating Acute Pain with a Formulated Drug Depot in Combination with a Liquid Formulation
10/22/2009US20090264488 Novel solid forms of bendamustine hydrochloride
10/22/2009US20090264487 Hemiasterlin analogs
10/22/2009US20090264486 Compounds, Compositions and Methods Comprising Isoxazole Derivatives
10/22/2009US20090264485 Pyrazole Derivatives, Their Manufacture and Their Use as Pharmaceutical Agents
10/22/2009US20090264484 Methods and Medicaments for Administration of Ibuprofen
10/22/2009US20090264483 METHODS OF USING PPAR-gamma AGONISTS AND CASPASE-DEPENDENT CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER
10/22/2009US20090264482 Chemical compounds
10/22/2009US20090264481 Compounds, Compositions and Methods Comprising Oxadiazole Derivatives
10/22/2009US20090264480 Trpa1 antagonists
10/22/2009US20090264479 Papain Family Cysteine Protease Inhibitors for the Treatment of Parasitic Diseases
10/22/2009US20090264478 Sulfasalazine formulations in a biodegradable polymer carrier
10/22/2009US20090264477 Beta adrenergic receptor agonists for treatment of pain and/or inflammation
10/22/2009US20090264476 CB-1 receptor modulator formulations
10/22/2009US20090264475 Methods and compositions for altering dietary behavior
10/22/2009US20090264474 Sulfonamides as trpm8 modulators
10/22/2009US20090264473 Novel Crystalline Forms of Antidiabetic Compounds
10/22/2009US20090264472 Methods and compositions for treating post-operative pain comprising a local anesthetic
10/22/2009US20090264471 Compounds, Compositions and Methods Comprising Triazole Derivatives
10/22/2009US20090264470 CB1 Antagonists and Inverse Agonists
10/22/2009US20090264469 Novel dicarboxylic acid derivatives
10/22/2009US20090264468 Methods for treating a disease in which Rho kinase is involved
10/22/2009US20090264467 Agents and crystals for improving excretory potency of urinary bladder
10/22/2009US20090264466 Certain Chemical Entities, Compositions and Methods
10/22/2009US20090264465 Crystalline forms of 4- [2- (4-methylphenylsulfanyl) -phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain
10/22/2009US20090264464 Antitumor agent for undifferentiated gastric cancer
10/22/2009US20090264463 Inhibitors Of Protein Phosphatase-1 And Uses Thereof
10/22/2009US20090264462 Kappa opioid receptor ligands
10/22/2009US20090264461 Polymorph of (R)-3- (2-Hydroxy-2, 2-Diphenyl -Acetoxy) -1- (Isoxazol-s-ylcarbamoyl-methyl)-1-Azoni A-Bicyclo-[2.2.2] Octane Bromide
10/22/2009US20090264460 Clopidogrel pharmaceutical formulations
10/22/2009US20090264459 Organic Compounds
10/22/2009US20090264458 5-ht7 receptor antagonists
10/22/2009US20090264457 Combination of at least two 5HT6-Ligands
10/22/2009US20090264456 Compostions and methods for preventing and/or treating disorders asociated with cephalic pain
10/22/2009US20090264455 Androgen Receptor Modulator Compounds and Methods
10/22/2009US20090264454 Combined hydrocodone and analgesic formulation and method
10/22/2009US20090264453 Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof
10/22/2009US20090264452 2-(Phenylamino)-Pyrimidin-5-Amides As Cannabinoid 2 Receptors Modulators for the Treatment of Immune or Inflammatory Disorders
10/22/2009US20090264451 6-1h-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents
10/22/2009US20090264450 Limk2 inhibitors, compositions comprising them, and methods of their use
10/22/2009US20090264449 Hair care compositions and methods for increasing hair diameter
10/22/2009US20090264448 Pyrazolo[1,5-a]pyrimidines, processes, uses and compositions
10/22/2009US20090264447 Pyrimidine compounds for combating pathogenic fungi and cancer
10/22/2009US20090264446 Condensed Pyridines as Kinase Inhibitors
10/22/2009US20090264445 (S)-3-Cyclopentyl-N-[1-(2-hydroxy-2-methyl-propyl)-1H-pyrazol-3-yl]-2-(4-methoxy-2-oxo-2,5-dihydro-pyrrol-1-yl)-propionamide, useful for the treatment of metabolic disorders such as non-insulin dependent diabetes; antidiabetic agents
10/22/2009US20090264444 Organic compounds
10/22/2009US20090264443 Treatment of organophosphate exposure with tetrahydroindolone arylpiperazine compounds
10/22/2009US20090264442 Pyrazole derivatives as sigma receptor inhibitors
10/22/2009US20090264441 Compounds, Compositions and Methods Comprising Oxadiazole Derivatives
10/22/2009US20090264440 Inhibitors of protein tyrosine kinase activity
10/22/2009US20090264439 Combination of a) N--4-(3-pyridyl)-2-pyrimidine-amine and b) a histone deacetylase inhibitor for the treatment of leukemia
10/22/2009US20090264438 Polymorphic forms of imatinib mesylate and processes for preparation of novel crystalline forms as well as amorphous and form alpha
10/22/2009US20090264437 4-Piperazinyl-Pyrimidine Compounds Suitable for Treating Disorders that Respond to Modulation of the Dopamine D3 Receptor
10/22/2009US20090264436 CB-1 receptor modulator formulations
10/22/2009US20090264435 Novel Aryl- and Heteroarylpiperazines
10/22/2009US20090264434 Pyridazinone glucokinase activators
10/22/2009US20090264433 Compounds, Compositions and Methods Comprising Triazine Derivatives
10/22/2009US20090264432 Piperidine and Morpholine Renin Inhibitors
10/22/2009US20090264431 Novel cathepsin c inhibitors and their use
10/22/2009US20090264430 Salt of morpholine compound
10/22/2009US20090264429 Aryl - Hydroxyethylamino - Pyrimidines and Triazines as Modulators of Fatty Acid amide Hydrolase
10/22/2009US20090264428 Renin Inhibitors
10/22/2009US20090264427 3-Cyanoquinolines, Methods for Preparation and Use as Insulin-like Growth Factor Inhibitors
10/22/2009US20090264426 Bicyclic aromatic substituted pyridone derivative
10/22/2009US20090264425 Chemical compounds
10/22/2009US20090264424 Vanilloid receptor ligands and their use in treatments
10/22/2009US20090264423 Serine-threonine protein kinase and parp modulators
10/22/2009US20090264422 Method of treating disease states using substituted pyrazole compounds
10/22/2009US20090264421 Methods and Compositions for Treating Cancer
10/22/2009US20090264420 Organic compounds
10/22/2009US20090264419 CYCLIC MALONAMIDES AS INHIBITORS OF Abeta PROTEIN PRODUCTION
10/22/2009US20090264418 such as [5-(4-cyclopentyl-piperazine-1-carbonyl)-1H-indol-2-yl]-pyrrolidin-1-yl-methanone, useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors
10/22/2009US20090264417 N-sulfonyl heterocyclic ring such as piperazine connected via sulfonyl group to another fused heterocyclic ring such as benzothiophene or indoline; peroxisome proliferator-activated receptor (PPAR); obesity, diabetes, hyperinsulinemia, metabolic syndrome X, polycystic ovary syndrome
10/22/2009US20090264416 N-benzyl,n'-arylcarbonylpiperazine derivatives
10/22/2009US20090264415 Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for medical treatment
10/22/2009US20090264414 Amide Derivatives and Pharmaceutical Use Thereof
10/22/2009US20090264413 Compositions and Methods for Treating Female Sexual Dysfunction
1 ... 2528 2529 2530 2531 2532 2533 2534 2535 2536 2537 2538 2539 2540 2541 2542 2543 2544 2545 2546 2547 2548 ... 7860